MQS Management
TXG icon

MQS Management’s 10x Genomics TXG Stock Holding History

MQS Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$213K Buy
+2,360
New +$138K 0.12% 345

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
IEQ Capital
IEQ Capital Foster City, California $23.5B AUM 29.01% 1-Year Est. Return

MQS Management's TXG Position: Q3 2026 in Review

MQS Management opened a new position in 10x Genomics (TXG) in Q3 2026: 2,360 shares worth $213K. The stake represents 0.12% of the portfolio and ranks #345 among its holdings.

257 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • MQS Management held 2,360 shares of 10x Genomics worth $213K as of Q3 2026.
  • 10x Genomics was a new MQS Management position in Q3 2026.
  • 10x Genomics made up 0.12% of MQS Management's portfolio in Q3 2026, its #345 holding.
  • 257 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on MQS Management's 13F filing for Q3 2026, filed 6 Nov 2026.